Centers for Disease Control and Prevention Guideline for the Prevention of Surgical Site Infection, 2017

JAMA Surg. 2017 Aug 1;152(8):784-791. doi: 10.1001/jamasurg.2017.0904.


Importance: The human and financial costs of treating surgical site infections (SSIs) are increasing. The number of surgical procedures performed in the United States continues to rise, and surgical patients are initially seen with increasingly complex comorbidities. It is estimated that approximately half of SSIs are deemed preventable using evidence-based strategies.

Objective: To provide new and updated evidence-based recommendations for the prevention of SSI.

Evidence review: A targeted systematic review of the literature was conducted in MEDLINE, EMBASE, CINAHL, and the Cochrane Library from 1998 through April 2014. A modified Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) approach was used to assess the quality of evidence and the strength of the resulting recommendation and to provide explicit links between them. Of 5759 titles and abstracts screened, 896 underwent full-text review by 2 independent reviewers. After exclusions, 170 studies were extracted into evidence tables, appraised, and synthesized.

Findings: Before surgery, patients should shower or bathe (full body) with soap (antimicrobial or nonantimicrobial) or an antiseptic agent on at least the night before the operative day. Antimicrobial prophylaxis should be administered only when indicated based on published clinical practice guidelines and timed such that a bactericidal concentration of the agents is established in the serum and tissues when the incision is made. In cesarean section procedures, antimicrobial prophylaxis should be administered before skin incision. Skin preparation in the operating room should be performed using an alcohol-based agent unless contraindicated. For clean and clean-contaminated procedures, additional prophylactic antimicrobial agent doses should not be administered after the surgical incision is closed in the operating room, even in the presence of a drain. Topical antimicrobial agents should not be applied to the surgical incision. During surgery, glycemic control should be implemented using blood glucose target levels less than 200 mg/dL, and normothermia should be maintained in all patients. Increased fraction of inspired oxygen should be administered during surgery and after extubation in the immediate postoperative period for patients with normal pulmonary function undergoing general anesthesia with endotracheal intubation. Transfusion of blood products should not be withheld from surgical patients as a means to prevent SSI.

Conclusions and relevance: This guideline is intended to provide new and updated evidence-based recommendations for the prevention of SSI and should be incorporated into comprehensive surgical quality improvement programs to improve patient safety.

Publication types

  • Practice Guideline

MeSH terms

  • Adrenal Cortex Hormones / administration & dosage
  • Anti-Infective Agents, Local / therapeutic use
  • Antibiotic Prophylaxis / methods
  • Anticoagulants / therapeutic use
  • Arthroplasty, Replacement / methods
  • Biofilms
  • Blood Glucose / metabolism
  • Blood Transfusion / methods
  • Drainage / methods
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Injections, Intra-Articular
  • Oxygen / administration & dosage
  • Postoperative Care / methods
  • Protective Clothing
  • Surgical Wound Infection / prevention & control*


  • Adrenal Cortex Hormones
  • Anti-Infective Agents, Local
  • Anticoagulants
  • Blood Glucose
  • Immunosuppressive Agents
  • Oxygen